The invention relates to compounds of formula (I): as defined in the application. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of MDM2 and/or MDM4, or variants thereof.
该发明涉及以下公式(I)的化合物:如在申请中定义。这些化合物适用于治疗由M
DM2和/或M
DM4的活性介导的疾病或疾病,或其变体。